Library / Laws / 117th Congress / House Bills / H.R. 4278
H.R. 4278
To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2021-06-30 | 1.6K | ⠃⠗⠋ |